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Women in Contemporary Cancer Research
Abstract
Despite recent advances, gender inequality persists in many scientific fields, 
including medicine. Thus far, no study has extensively analyzed the gender 
composition of contemporary researchers in the oncology field. We examined 40 
oncological journals (Web of Science, ONCOLOGY category) with different impact 
factors (Q1-Q4) and extracted all the articles and reviews published during 2015-
17, in order to identify the gender of their authors. Our data showed that women 
represent about 38% of all the authorships, both in articles and reviews. In relative 
terms, women are overrepresented as first authors of articles (43.8%), and clearly 
underrepresented as last or senior authors (<30%). This double pattern, also 
observed in other medical fields, suggests that age, or more specifically, seniority, 
may play some role in the gender composition of cancer researchers. Examining 
the pattern of collaboration, an interesting finding was observed: the articles 
signed by a woman in the first or in the last position roughly showed gender parity 
in the byline. We found also some differences in the content of the articles 
depending on which gender occupies the first and last positions of the authorships. 
Key words: women, gender, cancer, oncology. 
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Introduction
In the past few decades, there has been a growing interest in studying and supporting 
the participation of women in scientific research1. Nevertheless, despite important 
advances, gender imbalance persists in the research production in many scientific 
fields2, including medicine3-5. Examples of this interest in gender diversity in science 
would be the fact that Nature dedicated a special issue to ‘Women in Science’6 or that 
the influential medical journal The Lancet launched a thematic issue on ‘Women in 
Science, Medicine, and Global Health’7. Recently, the FRONTIERS IN CANCER 
RESEARCH conference (Oct, 2018), organized by the German Cancer Research 
Center (DKFZ), promoted gender parity by inviting leading women in the field. The result 
was that 82% of the invited speakers were women, a percentage opposite to the usual 
rate, according to the organizers8.
However, what is the actual percentage of women in cancer research? Thus far, no 
study has extensively analyzed the gender composition of contemporary researchers in 
the oncology field. To this end, we examined forty oncological journals with different 
impact factors, and we extracted all the articles and reviews published in a three-year 
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period in order to study the gender of their authors, almost one hundred and fifty 
thousand items. 
Method.
Sample data. We selected 40 journals indexed in Clarivate Analytics’ Web of Science 
(WoS) database. The selection consisted of 10 journals from each quartile (Q1-Q4) of 
the distribution of journals sorted by their Impact Factor (IF, JCR-2017), within the 
ONCOLOGY category, specifically, the top ten in each quartile (see journals in Table S1 
of Supplementary material). We extracted all the articles (12,080) and reviews (2,939) 
published in these journals between 2015-17, and we examined their authorships to 
determine their gender. 
Gender identification of authors. It was based on the first (given) names. The WoS, 
like most scientific databases, does not provide the authors’ gender. However, in 2008 
the WoS began to include the authors’ full names (field tag AF: Author Full Name), 
although a proportion of records still display only the authors’ initials. After a preprocess 
of normalization that eliminated initials accompanying given names and replaced 
hyphens with spaces, all the authors’ first names were matched through 
GenderChecker, a database that includes 102,142 worldwide names, classified as male, 
female, or unisex (acquired from http://genderchecker.com/). This database is being 
used in research9-12 and, according to the website, by the UN Refugee Agency. To 
increase the number of observations, we identified the gender of a large number of 
authors (about 10% of total), one by one, whose given names had been unmatched or 
classified as unisex, by locating biographical information or a photo on the Internet 
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(mainly on university or laboratory websites). The accuracy of the gender classifications 
was tested in a validation study included in the Supplementary material. As mentioned, 
the information on the authors’ gender is not directly provided by the scientific databases 
and it must be indirectly inferred from the given names. This is a usual procedure in 
studies of this nature that is not free of errors. However, we assume that the proportion 
of possible errors (men classified as women, or women classified as men) is small—
such as the validation study shows— and there is no reason to presume that these 
hypothetical mistakes and the missing values (only initials, unisex names, or unmatched 
names) are not random and they are gender biased. On the other hand, it should be 
noted that the GenderChecker database used in this study is more conservative than 
others databases of that type, such as API Gender (i.e., some names that API Gender 
classifies as male or female, GenderChecker classifies them as unisex in order to 
reduce possible errors).  
Procedure. Each variable of interest (author names and surnames, type of paper –
article or review–, title, year of publication, journal, keywords, etc.) was extracted using 
the BibExcel program13. This software is a toolbox that creates a file in which the values 
of an extracted variable are associated with each individual paper (identified with a 
number). Finally, the values of all the variables studied were merged in a master Excel 
database to perform the bibliometric analyses. 
Data availability.
The data that support the findings of this study are openly available in 
http://www.langproc.uji.es/WCR.html.
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Results and Discussion
Rate of women authors. The 12,080 articles extracted from the WoS database were 
signed by 127,803 authorships; and the 2,039 reviews were signed by 16,497 
authorships. From the total 144,300 authorships, and after excluding the authorships 
with only initials, unisex names, or given names that did not match the GenderChecker 
databasea, gender could be identified in 112,707 (78.1%) of them: 70,073 men and 
42,634 women. Therefore, women represent about 38% of all the known-gender 
authorshipsb, both in articles and reviews (Table 1, last row), which it is quite far from 
gender parity, but a somewhat larger proportion than the overall presence of women in 
science, a third of researchers2. Women constitute about half of U.S. medical students14 
– although the number of female applicants and matriculants has declined slightly in the 
last last years15. Bearing in mind that women today represent 49% of the associate 
members of the American Association for Cancer Research16, our proportion of 38% 
female authorships suggests that a gender gap occurs in the number of researchers 
who publish in peer-reviewed oncological journals.   
If we consider the impact factor (IF), no clear trend is observed in the journals 
grouped by quartiles (Table 1, Figure 1). In articles published in journals categorized 
within the first quartile (Q1) of the IF distribution, the percentage of women is 36.0%; it 
rises to 41.4% in the journals in Q2, falls to 36.0% in Q3, and reaches 39.4% in Q4. The 
a There were 6,597 unisex authorships (4.6% of total), and 24,996 authorships (17.3%) with only initials or 
unmatched (with the GenderChecker database) given names.
b The percentages of female or male authorships will always refer to the known-gender totals.
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percentages of women in reviews are 32.8%, 41.0%, 36.2%, and 45.0%, respectively for 
the four quartiles, Q1-Q4. See journals and data in the Supplementary material.
Please, place Table 1 and Figure 1 about here.
We also obtained the gender percentages as first or last author of the article by-lines. 
The first and last (or senior) places are usually key positions in many scientific fields, 
including health and medical sciences, except in fields where the convention calls for 
alphabetical order (e.g., high-energy physics, mathematics, or economics17). Indeed, in 
our sample, only 1.29% of the articles with three or more authors (or 0.40% of those with 
four or more authors) present the surnames in alphabetical order, which is not higher 
than the expected probability of incidental alphabetical authorship.
In relative terms, women are overrepresented as first authors of articles (compared to 
the overall rate), representing 43.8% of them (Table 1, last row). This pattern of relative 
overrepresentation of women as first authors is consistent throughout the four quartiles 
(Table 1, Figure 1). For example, it is striking that in the oncological journal with the 
greatest impact in the world (IF=244.586), CA-A CANCER JOURNAL FOR CLINICIANS, 
although women are less than half of the authors of articles, they represent 56.1% of the 
first authors; and JAMA ONCOLOGY almost achieves gender parity in its first authors 
(49.3%) (see Supplementary material). Filardo and colleagues3 observed that female 
first authorship increased significantly from 27% in 1994 to 37% in 2014 for articles 
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published in six high-impact medical journals; that proportion of 37% is very close to ours 
38% for the ten journals grouped in the first quartile of impact factor (Q1, see Table 1). 
Jagsi and colleagues examined the participation of women in peer-reviewed research 
analyzing the authorship of original articles published in six prominent medical journals 
over a period of 35 years4. They only studied first and senior (last listed) authors and 
found that the proportion of first authors who were women escalated from only 5.9% in 
1970 to 29.3% in 2004. Although the Jagsi et al.’s study ended a decade before ours 
and it was based only on high-impact journals, our proportion of women (43.8%) 
publishing as first authors in forty journals of different impacts (and 38% in the Q1 
category) suggests that perhaps the situation of women – and their future perspectives – 
in the cancer field is slightly better than in the general medical field. It should be noted 
that, in biomedical sciences, the first author is typically the one who has made the most 
significant contribution in terms of work and time dedicated; in many cases, the first 
authors are beginning researchers publishing their first postdoctoral papers. This relative 
overrepresentation of women as first authors (and, outstandingly, gender parity in 
oncological journals of very high impact, such as CA Cancer J Clin or JAMA Oncol) 
could be indicative of new female incorporations into cancer research publishing their 
first studies under the direction of senior researchers.  
On the contrary, our data show that women are clearly underrepresented as last 
authors in the article by-lines (compared to the overall rate), both in general (29.6%) and 
consistently for the journals in each quartile (Table 1, Figure 1). In biomedical sciences, 
this place is usually reserved for the senior or leading scientist on a research team17, 
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that is, the researcher who conceives the project, coordinates the efforts, supervises the 
work, etc. This function normally corresponds to a scientist with a consolidated and 
longer career. The Jagsi et al.’s analysis4 of articles published in six prominent medical 
journals found that the proportion of senior (last) authors who were women increased 
from a tiny 3.7% in 1970 to 19.3% in 2004 (a smaller figure than ours for 2015-17 in 
cancer field, 29.6%). In other study, Jagsi et al.18 calculated that only 16% of the editorial 
board members of sixteen prominent biomedical journals were women in 2005.
The comparative underrepresentation of women occupying senior positions in 
research teams should be put in relation to other data from academia. According to the 
Association of American Medical Colleges (AAMC)19, the current number of full-time 
faculty at all U.S. medical schools in 2019 are 75,771 (42.3%) women and 103,404 
(57.7%) men. The gender proportions by degree type are: faculty with MD only (women, 
41.1%, men, 58.9%); faculty with PhD or other doctoral degree (women, 43.8%, men, 
56.2%); faculty with MD and PhD, or MD and Other Doctoral Degree (women, 30.0%, 
men, 70.0%). If we examine the gender distribution of medical faculty by rank20, there is 
a clear pyramidal structure: women represent 59.1% of all the Instructors, 47.5% of the 
Assistant Professors, 38.7% of the Associate Professors, and only 25.7% of full 
Professors. Curiously, within the male collective the pyramid structure is lost in the last 
step: there are more full professors (28,595) than associate professors (22,481), 
presumably as a seniority effect from previous generations.      
In summary, this double pattern of relative overrepresentation of women as first 
authors and relative underrepresentation as last or senior authors, also observed in 
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other gender studies2,3,5 suggests that age, or more exactly, seniority, could play some 
role in the gender composition of cancer researchers. This may be good news in the 
sense that gender asymmetry could be reduced to a certain degree as new generations 
of women researchers are gaining seniority. 
Please, place Table 2 about here.
Journals. Table 2 presents percentages of women as authors of articles and reviews 
published during the 2015-17 period in the 40 journals selected for the present study. 
The journals that showed higher rates of female authors were: the JOURNAL OF 
ADOLESCENT AND YOUNG ADULT ONCOLOGY, with 67.7% women as authors of 
articles (82.1% as first authors; and 61.2% as last authors); CANCER EPIDEMIOLOGY 
BIOMARKERS & PREVENTION (overall: 53.0%, first author: 68.8%, and last author: 
51.5%); HEREDITARY CANCER IN CLINICAL PRACTICE (overall: 49.5%, first author: 
66.7%); and GYNECOLOGIC ONCOLOGY (overall: 47.3%, first author: 55.1%) (more 
details in the Supplementary material).
By contrast, the most “masculine” journals were: NATURE REVIEWS CANCER 
(women only represent 26.4% of the authors of articles, and 30.7% of the authors of 
reviews); ANNALS OF ONCOLOGY (female percentages: 28.3% in articles and 29.5% 
in reviews); BONE MARROW TRANSPLANTATION (28.4% in articles and 25.7% in 
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reviews); WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (28.4% in articles 
and 33.0% in reviews); and LUNG CANCER (29.4% in articles and 33.3% in reviews).
Pattern of collaboration. Cancer research is a very collaborative field. The articles 
from our sample were written by an average of 10.6 authors (15.8 in the journals of Q1), 
with a range from 1-480 authors; and the reviews were written by an average of 5.6 
authors, with a range from 1-358 authors.
Please, place Figure 2 about here.
We selected the articles with at least three co-authors and they were divided into two 
groups: a) articles signed by a man as first author and b) articles signed by a woman as 
first author. We repeated the procedure and divided the initial set of multi-author articles 
into two new groups: c) articles signed by a man as last/senior author and d) articles 
signed by a woman as last/senior author. Subsequently, we analyzed the gender 
composition of each group and observed a remarkable finding (Figure 2). The articles 
signed by a woman in the first or last/senior position roughly showed gender 
parity in the byline (50.1% men/49.9% women when a woman signed as first author, 
and 46.8% men/53.2% women when a woman signed as last/senior author, which was 
slightly female biased). We do not mean to say that there is a cause and effect 
relationship between the presence of women in one of these two key positions and near 
gender parity in the articles, but obviously these two facts are associated. It seems that 
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leading female researchers tend to co-publish with women more than leading male 
researchers do; or perhaps they work on subtopics that are relatively more appealing to 
women.
However, when the first author is a man, the gender composition of the byline is more 
asymmetrical (70.0% men/30.0% women, Figure 2), compared to the overall asymmetry 
(62.8% men/37.8% women), Χ2(df=1) = 58618.78, p < 0.0001. The same thing occurs 
when a man is the senior or last author of the article (67.5% men/32.5% women, Figure 
2), Χ2(df=1) = 18191.79, p < 0.0001.
If we consider only the first and last authors – without intermediate co-authors – a 
similar pattern emerges. The articles signed by a man in the senior/last position yield the 
following percentages: 60% are signed by a man as first author, and 40% by a woman. 
However, in the articles signed by a woman in the senior/last position the proportions 
are almost reversed: only 42.4% are signed by a man in the first position, whereas 
57.6% are headed by a woman. 
Content. We carried out an analysis of the scientific content of each article based on 
its keywords, specifically, the Keywords Plus assigned by the WoS database (ID field). 
We separated the keywords belonging to articles signed by a man as first or last author 
from the keywords belonging to articles signed by a woman as first or last author. Then, 
the keywords of each set were sorted and grouped by their corresponding frequencies, 
and we compared the ‘male’ set vs. the ‘female’ set to find differences in the relative 
weight of each keyword (see Table S5 of the Material Supplementary). Thus, the top 5% 
of the keywords, in both the ‘male’ and ‘female’ sets, included the terms: survival, 
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cancer, expression, and chemotherapy, but the ‘female’ set additionally contained –in 
the first place– the keyword breast-cancer.
Examining the rest of the keywords, some of the terms with a greater relative weight 
in the ‘female’ set were, in this order: women, united-states, metaanalysis, lung-cancer, 
mortality, follow-up, impact, ovarian-cancer, risk-factors, population, care, prognostic-
factors, cohort, health, prevalence, postmenopausal women, survivors, children, 
recommendations, body-mass index, physical-activity, human-papillomavirus, or 
cervical-cancer. That is, the articles signed by women as first or last authors tend to deal 
–more than the articles signed by men as first or last authors– with: a) specific or the 
most common cancers in women –except lung cancer, although not cell lung-cancer, 
which was more prominent in the ‘male’ set –; b) cancer in children; and c) 
epidemiological and prevention issues. This overall pattern is coherent with gender 
percentages found in the different journals.    
Conclusions.
After identifying the gender of 112,707 authors of 15,019 scientific papers (12,080 
articles and 2,939 reviews) published during a three-year period in 40 oncological 
journals of different impacts, we can draw the following conclusions:
 Women represent about 38% of authorships, of both articles and reviews, in 
contemporary cancer research.
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 Compared to the overall rate, women are relatively overrepresented as first 
authors (about 44%) and relatively underrepresented as last or senior authors 
(less than 30%).
 The pattern of collaboration of the articles shows an interesting finding: when a 
woman signs as first or last/senior author, the article authorship approximates 
gender parity.
 There are some differences in the scientific content of the articles depending 
on which gender occupies the first and last positions of the authorships.
 The double pattern of relative overrepresentation of women as first authors and 
their relative underrepresentation as last or senior authors, also found in other 
studies2,5,21, suggests that age, or more specifically, seniority, could play 
some role in the gender composition of cancer researchers. This is a 
hypothesis that further research will have to test. In any case, the age/seniority 
hypothesis would be a positive sign because it would mean that gender 
proportions could move towards more balanced values in the coming years.
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Table 1. Percentages of Women as authors of Articles and Reviews published during the 
2015-17 period in 40 journals selected from the Web of Science database (category 
ONCOLOGY). The journals are grouped by quartiles (Q1-Q4) according to their impact 
factor in the ONCOLOGY category (JCR-2017). In the Articles, the table presents overall 
percentages and percentages of women as first or last authors. Last position values were 
calculated for articles with at least three co-authors. 
Women (%)
Articles
Overall First author Last author Reviews
10 Journals (Q1)
10 Journals (Q2)
10 Journals (Q3)
10 Journals (Q4)
36.0%
41.4%
36.0%
39.4%
38.0%
51.3%
39.6%
48.6%
25.9%
34.1%
27.2%
32.0%
32.8%
41.0%
36.2%
45.0%
Total (All Journals) 37.8% 43.8% 29.6% 37.9%
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Table 2. Percentages of Women as authors of Articles and Reviews published during the 2015-17 period in 40 journals 
selected from the Web of Science database (category ONCOLOGY). The journals are sorted by their impact factor and 
grouped by quartiles (Q) in the ONCOLOGY category (JCR-2017). In the Articles, the table presents overall percentages 
and percentages of women as first or last authors. Last position values were calculated for articles with at least three 
co-authors. Bold: percentages greater than or equal to 45%. Absolute values are available in the Tables S3 and S4 of 
the Supplementary material
Women (%)
Articles Reviews
Q JOURNALS (Abbreviations)
Overall
First
author
Last
author
Q1 CA Cancer J Clin
Nat Rev Cancer
Lancet Oncol
J Clin Oncol
Nat Rev Clin Oncol
Cancer Discov
Cancer Cell
JAMA Oncol
Ann Oncol
J Natl Cancer Inst
42.9
26.4
30.8
37.6
36.1
38.1
35.0
39.8
28.3
43.1
56.1
14.3
26.5
39.7
40.6
41.1
46.0
49.3
25.8
45.5
17.5
16.7
20.5
29.2
25.0
21.5
18.4
30.7
23.1
31.6
51.8
30.7
33.5
37.9
30.2
22.6
11.8
30.0
29.5
33.2
Q2 Cancer Biol Med
Mol Cancer Res
J Environ Sci Health C Environ..
Cancer Epidemiol Biomarkers Prev
Gynecol Oncol
J Oncol
Bone Marrow Transplant
Crit Rev Oncol Hematol
Lung Cancer
Front Oncol
38.1
37.7
40.0
53.0
47.3
29.4
28.4
-
29.1
38.7
53.1
51.2
-
68.8
55.1
25.0
34.9
-
37.3
46.6
20.7
23.9
-
51.5
42.2
30.0
23.7
-
16.2
33.1
38.6
36.8
43.3
51.1
52.2
43.8
25.7
38.3
33.3
42.7
(cont.)
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Table 2 (cont.). 
Q3 Hematol Oncol
Surg Oncol Clin N Am
Oncol Res
World J Gastrointest Oncol
Melanoma Res
Curr Oncol Rep
Hematol Oncol Clin North Am
Transl Oncol
Am J Transl Res
Clin Oncol
41.4
32.4
35.9
28.4
45.3
44.4
34.3
35.8
32.1
31.7
43.3
36.2
35.9
29.4
52.4
50.0
44.3
44.9
31.5
40.4
27.6
19.3
31.6
17.9
35.4
47.1
17.9
28.9
26.1
23.1
40.5
-
29.4
33.0
35.1
40.4
41.9
31.9
27.4
17.9
Q4 J Adolesc Young Adult Oncol
J Contemp Brachytherapy
Infect Agent Cancer
Cancer Invest
Breast Cancer
Front Med
Hered Cancer Clin Pract
Cancer Control
Chemotherapy 
Curr Oncol
67.7
29.9
43.3
38.8
32.0
41.5
49.5
40.9
33.5
38.6
82.1
36.3
55.7
44.8
44.3
40.4
66.7
37.8
44.1
51.7
61.2
16.1
31.8
28.5
22.3
34.7
42.9
34.7
14.1
46.4
75.8
26.7
54.5
31.1
44.6
38.1
59.5
35.2
37.0
45.0
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Figure 1. Distribution of percentages of women as authors of Articles published during the 2015-17 period 
in the 40 journals selected from the Web of Science database (category ONCOLOGY). The journals are 
grouped by quartiles (Q1-Q4) according to their impact factor in the ONCOLOGY category (JCR-2017).  
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Figure 2. Percentages of authors (men and women) depending on which gender 
occupied the first or last/senior positions in the article byline. Values were calculated 
for articles with at least three co-authors. 
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